PRX as A Cancer Drug Target: Studies and Potential Targets (G57716)

Target Name: PRX

NCBI ID: G57716

PRX as A Cancer Drug Target: Studies and Potential Targets

PRX (PRostovskysin X) is a protein that is expressed in most tissues of the body and plays a critical role in cell signaling. It is a key regulator of the cytoskeleton and is involved in the process of cell division and the formation of organelles. PRX is also involved in the regulation of cell survival and has been linked to a number of diseases, including cancer.

Recent studies have identified PRX as a potential drug target (or biomarker) for a number of diseases, including cancer. PRX has been shown to be highly expressed in various types of cancer, including breast, lung, and ovarian cancer. It has also been shown to play a role in the regulation of cell cycle progression and the maintenance of stem cell properties.

One of the key challenges in the development of PRX as a drug target is its high expression in a wide range of tissues, making it difficult to target specific changes in the cell. However, researchers have been able to identify a number of potential targets for PRX, including changes in gene expression, protein localization, and the structure of the cytoskeleton.

One potential target for PRX is the protein tyrosine phosphatase (PTP), which is a enzyme that regulates the tyrosine phosphorylation of various proteins. PTP has been shown to play a role in the regulation of cell survival and has been linked to the development of cancer. Researchers have identified a number of potential PTP targets that are highly expressed in cancer cells, including PRX.

Another potential target for PRX is the protein kinase B-catenin (BKCAT), which is involved in the regulation of cell adhesion and the formation of tight junctions. BKCAT has been shown to play a role in the development of various types of cancer, including breast cancer. Researchers have identified a number of potential BKCAT targets that are highly expressed in cancer cells, including PRX.

In addition to these potential targets, researchers have also identified a number of potential biomarkers for PRX, including changes in gene expression, protein localization, and protein stability. These biomarkers may be useful for the diagnosis and monitoring of various types of cancer, including breast, lung, and ovarian cancer.

Overall, PRX is a protein that has been identified as a potential drug target (or biomarker) for a number of diseases, including cancer. While further research is needed to fully understand its role and to develop effective treatments, the studies that have been conducted to date suggest that PRX is a promising target for the development of new therapies.

Protein Name: Periaxin

Functions: Scaffolding protein that functions as part of a dystroglycan complex in Schwann cells, and as part of EZR and AHNAK-containing complexes in eye lens fiber cells. Required for the maintenance of the peripheral myelin sheath that is essential for normal transmission of nerve impulses and normal perception of sensory stimuli. Required for normal transport of MBP mRNA from the perinuclear to the paranodal regions. Required for normal remyelination after nerve injury. Required for normal elongation of Schwann cells and normal length of the internodes between the nodes of Ranvier. The demyelinated nodes of Ranvier permit saltatory transmission of nerve impulses; shorter internodes cause slower transmission of nerve impulses. Required for the formation of appositions between the abaxonal surface of the myelin sheath and the Schwann cell plasma membrane; the Schwann cell cytoplasm is restricted to regions between these appositions. Required for the formation of Cajal bands and of Schmidt-Lanterman incisures that correspond to short, cytoplasm-filled regions on myelinated nerves. Recruits DRP2 to the Schwann cell plasma membrane. Required for normal protein composition of the eye lens fiber cell plasma membrane and normal eye lens fiber cell morphology

More Common Targets